Table 3.
Combined Results of the Third and Fourth Delphi Round; Consensus* on Antibiotic Prescribing for Clinical Presentations of S&S in Which it was Assumed that UTI was not Ruled out by Additional Diagnostics
| Clinical Presentations with Consensus on Antibiotic Nonprescribing |
Clinical Presentations with Consensus on Antibiotic Prescribing |
Clinical Presentations without Consensus |
|---|---|---|
| One nonsevere UTI-specific S&S,† irrespective of the presence of nonspecific S&S‡ | One very bothersome UTI-specific S&S† with nonspecific S&S‡ | One very bothersome UTI-specific S&S† without any other S&S (57% would prescr be +7% if no other cause could be found) |
| Macroscopic hematuria, irrespective of the presence of nonspecific S&S‡ and whether the patients takes oral anticoagulants | At least 3 UTI-specific S&S†, irrespective of the presence of nonspecific S&S‡ | Two UTI-specific S&S†, irrespective of the presence of nonspecific S&S‡ (71% would prescribe +21% only if moderate/severe) |
| Prostate pain, irrespective of the presence of nonspecific S&S‡ | UTI-specific S&S† with new costovertebral angle pain/tenderness | New costovertebral angle pain/tenderness with systemic S&S (71% would prescribe +7% depending on the severity of the S&S) |
| New costovertebral angle pain/tenderness, irrespective of the presence of nonspecific S&S‡ | UTI-specific S&S† with new suprapubic pain | New suprapubic pain with systemic S&S (57% would not prescribe) |
| New suprapubic pain, irrespective of the presence of nonspecific S&S‡ | New costovertebral angle pain/tenderness with systemic S&S and nonspecific S&S‡ | Urinary retention with UTI-specific S&S† (69%would prescribe) |
| New scrotum pain, irrespective of the presence of nonspecific S&S‡ | ||
| Urinary retention, irrespective of the presence of nonspecific S&S‡ | ||
| One or more nonspecific S&S‡ |
Consensus was defined as an agreement level of _75%.20
UTI-specific S&S, after the first 2 Delphi rounds defined as dysuria, new urgency, new frequency, new incontinence, and (visible) urethral purulence.
Nonspecific S&S, after the first 2 Delphi rounds defined as: agitation/aggression (new or worsening), decreased dietary intake, decreased fluid intake, decreased functional status/ADL, decreased mobility, decreased urinary output, diarrhea, dizziness (new or worsening), fatigue (new or worsening), general lack of well-being, malaise, mental status change without a clinical suspicion of delirium, nausea (with or without vomiting), nocturia, syncope, and weakness (new or worsening).